ORIC Pharmaceuticals Inc.

NASDAQ: ORIC · Real-Time Price · USD
9.72
-0.21 (-2.11%)
At close: Aug 15, 2025, 3:59 PM
9.62
-1.03%
After-hours: Aug 15, 2025, 07:13 PM EDT

ORIC Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-137.25M -132.86M -127.85M -119.87M -110.78M -101.76M -100.7M -93.21M -92.56M -89.91M -89.12M -91.05M -84.64M -85.36M -78.72M -84.2M -91.33M -81.34M
Depreciation & Amortization
1.19M 1.15M 1.11M 1.07M 1.05M 1.04M 1.03M 1.02M 980K 968K 966K 948K 944K 919K 897K 902K 925K 949K
Stock-Based Compensation
23.39M 21.81M 20.21M 18.93M 17.74M 16.57M 15.23M 14.43M 13.86M 14.13M 14.46M 14.83M 14.93M 14.05M 12.85M 11.04M 9.33M 7.5M
Other Working Capital
1.88M 1.98M 143K -206K -2.12M -1.89M 1.62M 1.39M 3.53M 2.17M 530K -115K -1.28M -826K 1.14M -2.11M -2.67M -3.34M
Other Non-Cash Items
-5.05M -6.76M -8.27M -5.28M -5.25M -4.21M -2.68M -4.62M -3.06M -2.06M -1.16M -1.8M -1.1M -413K -14K 8.07M 20.75M 21.93M
Deferred Income Tax
n/a n/a n/a -3.47M -3.47M -3.47M -3.47M n/a n/a n/a n/a 1.36M 1.36M 1.36M 1.36M 266K 266K 266K
Change in Working Capital
-2.5M 1.65M 1.97M -428K 817K -3.58M 4.9M 5.63M 4.37M 3.66M -445K -555K -580K 2.08M 4.07M 2.83M 1.54M 423K
Operating Cash Flow
-120.23M -115.01M -112.83M -109.05M -99.89M -95.41M -85.69M -76.75M -76.42M -73.05M -75.14M -76.1M -68.92M -67.36M -59.54M -61.08M -58.52M -51.89M
Capital Expenditures
-1.02M -1.36M -1.19M -1.03M -685K -757K -849K -1.08M -1.4M -1.67M -2.08M -2.18M -2.01M -1.48M -939K -961K -778K -845K
Cash Acquisitions
n/a n/a n/a -21.02K 36.73K 55.64K 365.64K 2.46M 2.41M 2.39M 2.8M 2.1M 2.1M 2.1M 1.64M -124.57M -124.57M -124.57M
Purchase of Investments
-277.67M -202.19M -251.92M -246.26M -303.24M -310.25M -239.24M -241.91M -191.94M -181.57M -238.12M -243.25M -189.93M -144.39M -69.63M -133.71M -250.66M -250.66M
Sales Maturities Of Investments
290M 310M 275.25M 247.74M 223.47M 192.96M 196.69M 206.92M 214.42M 177.43M 130.95M 108.23M 90.5M 173M 229M 201.5M 158.5M 76M
Other Investing Acitivies
-969K -969K -969K -947.98K -36.73K -55.64K -365.64K -2.46M -2.41M -47.92M -48.34M -47.63M -12.33M 115.71M 116.17M 242.38M 82.43M -67K
Investing Cash Flow
11.24M 106.45M 22.14M 445K -80.46M -118.05M -43.4M -36.07M 21.08M -5.81M -109.25M -137.2M -101.44M 27.13M 158.44M 66.83M -92.93M -175.5M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
124.92M 125.33M 125.77M 425K 425K 599K 401K -33K -32K 209K 225K 1.25M -170K -866K -866K -9.49M -8.42M 118.85M
Financial Cash Flow
135.01M 1.53M 126.72M 126.59M 126.5M 210.86M 85.66M 110.4M 110.37M 25.61M 25.62M 1.25M 49.83M 49.13M 49.13M 173.82M 124.89M 252.16M
Net Cash Flow
26.03M -7.03M 36.02M 17.99M -53.85M -2.61M -43.43M -2.81M 54.63M -53.65M -159.17M -212.05M -120.53M 8.9M 148.03M 179.56M -26.56M 24.77M
Free Cash Flow
-120.86M -115.98M -114.02M -110.3M -100.81M -96.4M -86.76M -77.83M -77.83M -74.72M -77.22M -78.28M -70.93M -68.84M -60.48M -62.04M -59.3M -52.73M